NNC0487-0111 for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Sep 2023: Trial started, NCT06049329
  2. 22 Sep 2023: Trial registered, NCT06049329

The trials

NCT06049329: A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity

State
Completed
Phase
Phase 1
People
36 taking part
Started
14 Sep 2023
Primary completion
15 Dec 2023
Arms
NNC0487-0111
Results
None posted
  1. 14 Sep 2023: Trial started
  2. 22 Sep 2023: Trial registered
  3. 15 Dec 2023: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.